Tethys Investments

Tethys Investments is a private equity firm established in 2017 and based in Boston, Massachusetts. The firm specializes in lower-middle-market investments, focusing on growth and distressed assets in Eurasia. Tethys emphasizes regional and country specialization, industry expertise, and rigorous due diligence, combining quantitative analysis with field-intensive qualitative assessments. The firm selectively invests in sectors such as energy, transportation, financial services, agriculture, manufacturing, IT services, and hospitality. Tethys aims to identify investment opportunities that lead to the development of stronger companies, prioritizing social responsibility and long-term returns. Additionally, when favorable exit options are identified within a 5-10 year timeframe, Tethys is open to investing in greenfield projects.

Ramil Maharramov Muzaffarsky

Managing Partner and Founder

6 past transactions

Ceva Santé Animale

Private Equity Round in 2025
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.

Septeo

Private Equity Round in 2024
Septeo Group is a provider of legal technology services aimed at notaries, law firms, corporate legal departments, and real estate property managers. The company offers a range of solutions, including infrastructure management, digital communication, enterprise resource planning (ERP) software, managed cloud services, and outsourcing facilities. By delivering these services, Septeo Group helps its clients simplify their operations and concentrate on their core business activities. The organization is structured to leverage the latest digital tools, ensuring that each entity within the group can focus on its business expertise while providing excellent service to its customers.

The Row

Private Equity Round in 2024
The Row is a designer and manufacturer based in New York, specializing in a diverse range of ready-to-wear clothing and accessories for women, men, and children. The company offers a variety of products, including clothing, eyewear, handbags, and footwear, with an emphasis on fine fabrics and impeccable fit.

Sezane

Venture Round in 2022
Sézane is a French company that specializes in the manufacture of clothing and accessories. It offers a comprehensive range of ready-to-wear apparel, including dresses, footwear, and various lifestyle products. The brand is committed to enhancing quality and creativity in its designs, utilizing premium fabrics to deliver stylish options at competitive prices. Sézane aims to provide customers with high-quality clothing that reflects contemporary trends while maintaining a focus on craftsmanship.

Ceva Santé Animale

Venture Round in 2020
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.

M2i Life Sciences

Private Equity Round in 2019
M2i Life Sciences is a French company that specializes in custom synthesis and formulation of niche products across several sectors including healthcare, veterinary medicine, biological crop protection, and organic electronics. The company excels in redesigning synthetic routes and industrial processes for complex molecules, offering clients comprehensive services from product specification to regulatory clearance. M2i operates an R&D center and a cGMP manufacturing plant in France. Additionally, the company manufactures biocontrol products for agricultural ecological transition, focusing on the development of pheromones that provide alternatives to chemical insecticides, thereby promoting biological diversity and animal welfare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.